Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Acta Tropica
- Vol. 216, 105836
Abstract
No abstract availableKeywords
Funding Information
- Tarbiat Modares University
This publication has 54 references indexed in Scilit:
- Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondiiParasites & Vectors, 2013
- Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticlesParasites & Vectors, 2013
- Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c miceParasites & Vectors, 2012
- Tools and collaborative environments for bioinformatics researchBriefings in Bioinformatics, 2011
- Toxoplasma in Animals, Food, and Humans: An Old Parasite of New ConcernFoodborne Pathogens and Disease, 2011
- CpG DNA as a vaccine adjuvantExpert Review of Vaccines, 2011
- Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in miceParasitology Research, 2009
- Vaccination against Murine Toxoplasmosis Using Recombinant Toxoplasma gondii SAG3 Antigen Alone or in Combination with Quil AYonsei Medical Journal, 2007
- AlgPred: prediction of allergenic proteins and mapping of IgE epitopesNucleic Acids Research, 2006
- Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondiiVaccine, 2004